Research News & Funding Opportunities for Tulane Cancer Researchers - August 27, 2024 | |
|
2024 Man Up! Geaux Get Screened!
Saturday, September 7
9 AM – Noon
East Jefferson General Hospital
Esplanade 1 Conference Room, 1st Floor
4200 Houma Blvd., Metairie
The New Orleans Saints and Tulane Urology are teaming up at East Jefferson General Hospital to raise prostate cancer awareness and provide free PSA blood tests to eligible men.
Fans can snap photos with New Orleans Saints Hall-of-Famer Rickey Jackson, former Saints Quarterback Bobby Hebert, and other NFL greats while learning prostate cancer prevention tips, risk factors and the latest treatment information from Tulane's expert doctors and researchers.
Families and men of all ages are welcome, but screening spots are limited to the first 100 eligible men. Free parking is available in the Hudson Garage, located on the west side of the hospital.
For more information on Man Up, please contact Tulane Urology at 504-988-2750. Please help us spread the word.
| |
LCRC & ACS Extramural Discovery Science Grants Workshop
Wednesday, August 28 - 11:45 AM - 1 PM
Online Event
The “Extramural Discovery Science Grants Workshop” will provide attendees with information on:
- American Cancer Society-funded grants and new research opportunities
- “Insider Tips” for a successful application process
- How grant applications are evaluated
- Understanding success rates for future funding
- Online resources available
This workshop is available to all LCRC faculty members.
| |
Association of Clinical Research Professionals Gulf States Local Chapter Kickoff Social
Wednesday, August 28 - 5:30 - 8:00 PM
Central City BBQ
1201 S. Rampart St., New Orleans, 70113
The ACRP Gulf States Local Chapter is thrilled to invite clinical research professionals -- faculty, staff and research students -- to join the local chapter kickoff social for an evening filled with networking and delicious BBQ small plates. This in-person event is a great opportunity to connect with fellow professionals in the industry and gain valuable insights. A cash bar will be available in the main restaurant.
Registration is required! Please click here to register.
Questions? Email Wesal Abualkhair, MD, MS, MS, at wabualkh@tulane.edu.
| |
POSTDOC FUNDING: NIH MOSAIC K99 Program to Promote Faculty Diversity
Informational Webinar
Thursday, August 29 - Noon
Register here
The MOSAIC program is designed to facilitate the transition of promising postdoctoral researchers from diverse backgrounds into independent, research-intensive faculty careers. The program has two components: an individual career transition award for postdoctoral scholars (K99/R00) and a research education cooperative agreement (UE5) awarded to organizations to provide these scholars with additional mentoring, networking and professional development activities to support their transition to and success in independent faculty careers. The MOSAIC K99/R00 program supports researchers who have demonstrated meaningful contributions and proposed compelling future plans to promote broad participation in the biomedical research workforce.
NIH accepts applications for the MOSAIC K99/R00 award three times per year, and the next application receipt date is October 12. Please note, the MOSAIC K99/R00 award is limited to US Citizens and Permanent Residents.
| |
Approaching Deadlines for Department of Defense Award Mechanisms
Kidney Cancer Research Program
Academy of Kidney Cancer Investigators - Leadership Award
o Pre-application (Letter of Intent) - August 29 -
4:00 p.m. Central Time
o Application submission deadline is September 19, 2024 - 10:59 p.m. Central Time
| |
Robert L. Fine Cancer Research Foundation Pancreatic Cancer Research Grant
Application Deadline: August 31, 2024
Grant Amount: $250,000 (direct costs only)
For more information, click here.
The Robert L. Fine Cancer Research Foundation distributes two awards every other year to outstanding young scientists dedicated to basic and translational pancreatic cancer research. The grant is intended to support research projects that can be carried out in a short period of time with limited resources. The topic of the requested grant applications will be for innovative translational pancreatic cancer research that focuses on bench to bedside advances. The grant mechanism supports different types of basic and translational projects, including pilot and feasibility studies, self-contained research projects, development of new research methodology and development of new research technology. This grant does not support solely clinical research.
The length of the grant will be for two years payable in yearly installments. Pre-award costs are allowable, up to 30 days prior to the grant initiation date; however, the incurrence of pre-award costs imposes no obligation on the foundation to grant the award. Funding for awardees will start January 1, 2025.
| |
|
Leveraging Your Online Researcher Profile
Free Webinar
Tuesday, September 3 - 10 AM
Register HERE
Being easily found and contacted online by different stakeholders such as journal editors, industry professionals, journalists and fellow researchers is crucial in fostering collaborations and advancing your career. But knowing where and how to build your online researcher profiles can be an intimidating task. The new Nature Masterclasses course on Building a Strong Online Researcher Profile is packed full of valuable and practical tips to help you get started.
In this corresponding webinar, you will learn
- the importance of having a strong online researcher profile
- how and when journal editors, industry professionals and journalists look for researchers
- advice for standing out from the crowd
| |
Matas Library Open House
Monday, September 9 - 10:00 AM - Noon
Matas Library Commons
Hutchinson - 2nd Floor
Free Refreshments
This is a great opportunity to meet library staff, become familiarized with information services and resources, view the comfortable study and relaxation spaces, and share your ideas to help the Matas Library meet your needs now and into the future.
| |
|
President Fitts’ State of the University Address – RSVP Now!
Faculty and staff are invited to President Michael A. Fitts' State of the University address on September 10 and 11.
The address will be held on the downtown campus on September 10 from 9:30 to 10:30 a.m. in Hutchinson Auditorium, and from 2 to 3 p.m. in the Kendall Cram Lecture Hall at the Lavin-Bernick Center on the uptown campus.
On September 11, the address will be held at the Tulane National Primate Research Center campus from 1 to 2 p.m. in the TNPRC Auditorium.
Please remember to bring your Splash Card. RSVP by clicking your preferred date above.
| |
|
CARES Center Pilot Project Funding
Letter of Intent Due: Friday, September 6, at Midnight
Full Application Due: November 18
Grant Amount: $100,000
VIEW RFA here.
The Cancer Awareness, Research, Engagement, and Support Center invites applications for pilot and feasibility studies to address disparities across the cancer control continuum in areas characterized by persistent poverty. Persistent poverty areas are here defined as Census tracts with ≥20% of residents living in poverty for ≥30 years.
Funding
Two pilot projects will be funded. Project budgets may not exceed $50,000 per year in total costs. Funding is for one year, with a possibility to apply for an additional year of funding contingent upon availability of funds. Faculty salary support is an allowable expense.
Eligibility
Preference will be given to proposals that include at least one early-stage investigator. Early-stage investigators applying as PIs must be mentored by a senior faculty member with a strong record of NIH funding in the area related to the proposed research. Early-stage investigators will participate in training provided by the CARES Career Enhancement Core.
If interested, please submit a letter of intent (LOI) to Kaitlyn Waugaman, kjwaugaman@uabmc.edu.
| |
|
PROVOST'S PROOF OF CONCEPT FUND - FALL 2024
APPLICATION DEADLINE:
FRIDAY, SEPTEMBER 6
GRANT AMOUNT: UP TO $50,000
This grant is designed to help advance promising ideas and technologies to become market-ready.
- This is a competitive funding opportunity with minimal administrative lift.
- $50,000 will be dispersed based on a mutually agreed-upon timeline and two to three milestones.
- Projects will be judged based on technical merit and feasibility as well as commercial potential. Customer discovery and competitive intelligence must be included as part of the application. The focus is to uplift scalable technologies, products, and services.
Outside industry experts will be used to help evaluate the merit of projects.
Members of the Tulane community (faculty, staff, graduate students, PhD students, fellows and post-docs) with an invention disclosure filed or in preparation and an identified commercial application for the proposed technology or invention are welcome to apply.
Please apply using the StartupWind platform here. Additional information can be found on the Tulane University Innovation Institute website here. You can also check out the Tulane Innovation Institute's portfolio of funded projects at this link.
Questions? Contact Jillian L. Delos Reyes at JDelosReyes@tulane.edu.
| |
Request for Proposals
Equity in Access Research Program
LETTERS OF INTENT DEADLINE:
SEPTEMBER 12, 2 PM CDT
The Leukemia & Lymphoma Society (LLS) has reissued the RFP Building Evidence for Effective Interventions to Increase Therapeutic Cancer Clinical Trial Accrual: Promoting Access for Patients from Underrepresented Groups. Awards will be a maximum of $2.5 million each, over 5 years.
Specifically, they seek proposals that will implement and evaluate interventions designed to:
- Mitigate multilevel barriers to therapeutic clinical trial accrual for underrepresented groups
- Quantitatively measure the impact of these interventions on patient accrual
They are particularly interested in proposals that address systemic, institutional, and clinician-related barriers that impede clinical trial participation. It is not necessary for applicants to have previously conducted research in blood cancer.
For more information, please click here.
| |
2025 Macy Faculty Scholars Program
Call for Applications
APPLICATION DEADLINE: SEPTEMBER 15
AWARD AMOUNT: UP TO $250,000 OVER TWO YEARS
The 2025 Macy Faculty Scholars Program aims to identify and nurture promising early-career educators in medicine and nursing. Macy Faculty Scholars receive up to $250,000 of salary, project, and professional development support over two years to implement an educational project in their home institutions.
Visit the website to learn more about the program and get started on your application.
|
|
Clinical Trial Grant Opportunity to Increase Black Patient Enrollment for Prostate Cancer Clinical Trials
LETTERS OF INTENT DUE:
SEPTEMBER 16
GRANT AMOUNT: UP TO $200,000 DIRECT COSTS/YEAR FOR TWO YEARS
To increase participation of Black men with prostate cancer in clinical trials, ACS is announcing a funding opportunity to support community oncology practices and hospitals in their efforts for clinical trial enrollment. Eligible practice-based applicants must have direct patient interaction and the capability to participate in clinical trials.
ACS will provide awardees up to $200,000 direct costs per year for two years to build the infrastructure needed to increase clinical trial enrollment. These funds may be used to support clinical staff involved in recruitment and trial enrollment as well as any infrastructure needed to engage men with prostate cancer.
Interested applicants must submit a letter of intent through ProposalCentral. Upon receipt, ACS will provide appropriate guidance to ensure applications are within the scope of this funding announcement and more information about the application process.
For more information, click here: Press Releases (cancer.org)
| |
NOSI: Analysis of Existing Linked Datasets to Understand the Relationship between Housing Program Participation and Risk for Chronic Diseases and Other Conditions (R01 - Clinical Trial Not Allowed)
FIRST AVAILABLE DUE DATE: OCTOBER 7
https://grants.nih.gov/grants/guide/notice-files/NOT-DK-24-029.html
This NOSI invites applications proposing to conduct secondary analyses to evaluate the health effects of participation in housing-related programs using existing administratively linked datasets. Applicants may use data science, mixed methods, and other computational approaches to analyze these data. Applicants are encouraged to examine multi-level constructs that include individual and contextual factors, such as social determinants of health, (e.g., neighborhood characteristics, food insecurity, transportation, and healthcare access, etc.) as well as participation in other social services/programs to examine how these factors may interact to impact prevention, onset and progression, and/or treatment of chronic disease and other health conditions. Comorbidities involving chronic diseases, inclusive of multiple co-morbidities, may also be assessed.
Applications proposing to collect new data would not be responsive to this NOSI.
| |
 |
2024 Michael F. Priceman Memorial Grant
APPLICATIONS DUE: NOVEMBER 1 - 10:59 PM CDT
GRANT AMOUNT – Up to $500,000 over 2 years
INDIRECT COSTS – 15%
The RFA is for pre-clinical or translational work for gastroesophageal cancer that will lead to a clinical trial within two years. This is to accelerate drug development and to bring new therapies to patients as quickly as possible. Up to two grants will be awarded with a completion date of two years. Grants may be supported in full or partially based on the aims of the project, novelty and feasibility.
Eligibility:
- Applicants must be employed by a non-profit academic institution. Applications will be accepted from both U.S. and non-U.S. entities.
- No applications will be accepted from post-docs, or individuals without a faculty appointment.
- We encourage interdisciplinary collaborations and welcome proposals from independent investigators at all career stages, especially those new to the field of upper GI cancers.
For more information or to download the application, click here.
Questions? Contact sarah@degregorio.org.
| |
NSF 24-598: Mid-Scale Research Infrastructure-1
PRELIMINARY PROPOSAL DUE DATE: NOVEMBER 18, 2024 - 5:00 PM CDT
FULL PROPOSAL DEADLINE: MARCH 19, 2025 - 5:00 PM CDT
NSF 24-598: Mid-scale Research Infrastructure-1 (Mid-scale RI-1) | NSF - National Science Foundation
***Full proposal is by invitation only***
The Foundation-wide Mid-scale Research Infrastructure opportunity is intended to provide NSF with an agile, Foundation-wide process to fund experimental research capabilities in the mid-scale range between MRI and Major Multi-user Facilities.
“Implementation" projects may have a total project cost ranging from $4 million up to but not including $20 million. Only "Design" activities may request less than $4 million, with a minimum request of $400,000 and a maximum request up to but not including $20 million.
There are no limits to the number of preliminary proposals submitted as the lead organization. Full proposals are to be submitted only if/when invited by NSF. There is no limit to participation as a partner organization or sub-awardee.
| |
|
Gilead’s Research Scholars Program in Oncology Solid Tumors
APPLICATION DEADLINE: DECEMBER 6, 2024, at 11:59 PM PST
GRANT AMOUNT: UP TO $180,000
Apply here: Research Scholars Program Solid Tumors Portal
The Research Scholars Program supports any basic and clinical research limited to breast, bladder, upper gastrointestinal, or lung cancer that addresses an unmet medical need in the field of Oncology Solid Tumors.
Gilead’s Research Scholars Program selects junior faculty researchers pursuing an academic career at an institution at the time of application of up to $180,000 USD paid directly to the researchers' institution in 2 annual installments subject to Program terms and conditions, legal requirements, and applicable institutional rules.
Applicants must meet the following requirements:
1. MD or PhD (or an equivalent degree) at time of award
2. Received an initial faculty appointment within the last 7 years in association with a research institution in the United States at the time of application
3. This award is intended for early career investigators only
4. A strong career interest in oncology solid tumors
5. A research mentor with extensive experience in the field of oncology solid tumors
6. Able to devote at least 30% of their professional time to research for the next two years
7. Be able to complete the proposed research within the two-year award period
| |
|
Tulane Network Maintenance to Disrupt LCRC Network Connectivity Thursday Morning
Tulane will be performing network maintenance which will disrupt Louisiana Cancer Research Center network connectivity on Thursday, August 29, 6:00 - 7:00 AM.
Principal Investigators in the LCRC are asked to inform their teams of the planned outage. A follow-up email will be sent Thursday morning once Tulane Cancer Center Administration receives confirmation that the work has been completed.
| |
|
American Association for Cancer Research 2025 Scientific Achievement Awards & Lectureships Nominations
(AACR) is accepting nominations for its prestigious 2025 Scientific Achievement Awards and Lectureships until Sunday, September 15, 2024.
The AACR Scientific Achievement Awards Program recognizes scientific excellence across the full spectrum of basic, translational, clinical, and epidemiological cancer research. Through its awards and lectureships, the AACR honors scientists, clinicians, and physician-scientists who have made significant contributions to our understanding of cancer diagnosis, prevention, and treatment. Individuals who are now or have been affiliated with any cancer research institution may nominate a deserving colleague for an award or lectureship.
The following awards and lectureships are open for nominations:
Recipients will be recognized at the AACR Annual Meeting 2025 in Chicago. The 2024 AACR Scientific Achievement Awards and Lectureships recipients list is available on the AACR website.
For more information, visit the AACR website or contact Michael J. Powell, PhD, Senior Director of Scientific Programs and Strategic Initiatives, at michael.powell@aacr.org or 215-440-9373.
| |
|
Feedback Requested: Training Grant Applications
The upcoming 2024 CCTS Translational Symposium will include a session detailing pain points and best practices when developing training grant applications. In order to make this session as relevant and useful as possible, you are invited to participate in a very brief survey which should take fewer than three minutes to complete. Your responses will help focus attention on aspects of training grant applications most important to applicants.
If you have any questions or comments, please contact Andy Barton at abarton1@tulane.edu.
| |
LOGAN Modules and BoRSF Information Session Registration
Modules for notice of intent and proposal submission are now available via PI LOGAN accounts. Please note that modules are staged for those programs requiring a notice of intent, with proposal submission modules available only after all NOIs have been received and accepted. If potential applicants have issues accessing the modules, they should email rsi@laregents.edu.
In addition, to provide opportunities for faculty and staff to learn and ask questions about BoRSF programs, staff are hosting two types of online informational sessions: a general information webinar and one-on-one sessions with Senior Grant Programs Administrator, Mr. Bryan Jones. Registration links for these sessions are now available at https://rsi.laregents.edu/borsf-informational-sessions-fy-2024-25-competitions/.
| |
|
Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in lethal prostate cancer. Chauhan PS, Alahi I, Sinha S, Ledet EM, Mueller R, Linford J, Shiang AL, Webster J, Greiner L, Yang B, Ni G, Dang HX, Saha D, Babbra RK, Feng W, Harris PK, Qaium F, Duose DY, Sanchez-Espitia A, Sherry AD, Jaeger EB, Miller PJ, Caputo SA, Orme JJ, Lucien F, Park SS, Tang C, Pachynski RK, Sartor O, Maher CA, Chaudhuri AA.
Clin Cancer Res. 2024 Aug 23. doi: 10.1158/1078-0432.CCR-24-1658. Online ahead of print. PMID: 39177583
Screening of a kinase inhibitor library identified novel targetable kinase pathways in triple-negative breast cancer. Rinderle CH, Baker CV, Lagarde CB, Nguyen K, Al-Ghadban S, Matossian MD, Hoang VT, Martin EC, Collins-Burow BM, Ali S, Drewry DH, Burow ME, Bunnell BA. Anticancer Drugs. 2024 Aug 21. doi: 10.1097/CAD.0000000000001658. Online ahead of print. PMID: 39163320
|
|
Connect with Us on Social Media | |
Please visit Tulane Cancer Center on Facebook, Instagram and LinkedIn and follow us for all the latest news in cancer research, education and patient care.
You can access our profile pages by clicking on the icons below.
| |
|
Tulane Cancer Center now has an institutional subscription to The Cancer Letter, an independent weekly newsletter that is the leading source of information on:
- National Cancer Institute
- National Institutes of Health
- Food & Drug Administration
- the development of cancer therapies
- cancer research funding
- health care finance
- cancer legislation and policy
- clinical issues
- the pharmaceutical industry
Our institutional subscription allows anyone with a Tulane IP address to be automatically logged in when visiting www.cancerletter.com. From there you can view current and previous issues of the publication, with no need to create an individual account.
For more information, please click here.
|
|
Acknowledging Tulane Cancer Center Support in Publications
One of the responsibilities of membership in the Tulane Cancer Center is acknowledgement of Cancer Center membership and/or use of shared resources, salary support or other Tulane Cancer Center funding in presentations and publications
We suggest using the following wording when acknowledging Tulane Cancer Center support: "This work was supported by the Tulane Cancer Center, part of Tulane School of Medicine, and a consortium partner of the Louisiana Cancer Research Center."
| |
Tulane Cancer Center Branded Assets
Tulane Cancer Center has recently undertaken a brand refresh that not only streamlines and modernizes the look and feel of our brand but also aligns us more closely with the School of Medicine branding.
With that in mind, we have developed a full suite of branded assets for your immediate use, including:
- A Tulane Cancer Center-branded PowerPoint Slide Master
- A Tulane Cancer Center-branded Scientific Poster Template (sized at 4 feet x 3 feet)
- Tulane Cancer Center-branded Zoom Backgrounds
- Tulane Cancer Center’s updated logo
- Tulane Cancer Center-branded Email Signature Blocks
All Tulane Cancer Center Members should have received these files via a recent listserv email. If you did not receive the email but would like to begin using these templates, please contact Melanie Cross at mcross@tulane.edu.
Please also continue to acknowledgement your Tulane Cancer Center membership and/or use of shared resources, salary support or other Tulane Cancer Center funding in all presentations and publications.
Thank you for your assistance in helping us to expand our visibility while showcasing the depth and breadth of our outstanding basic, translational and population science research and clinical care.
| |
|
The Tulane Cancer Center NGS Analysis Core team assists investigators with furthering their research through comprehensive processing and analysis of data obtained from widely used high-throughput sequencing applications.
More Information
| |
Cell Analysis Core
The Cell Analysis Core Facility is designed to collaborate with investigators and contribute to all aspects of the research process, including consultation in experimental design, data analysis and storage, troubleshooting, interpretation of results, and the preparation and production of presentation graphics.
More Information
| |
Tulane Cancer Center & LCRC Membership
Any Tulane University faculty member whose research relates to or could potentially relate to cancer – directly or indirectly – should become a member of the Tulane Cancer Center (TCC). As a member, you have access to TCC's funding opportunities, research collaboration events, and shared resources. Please click here for our membership guidelines and our online application form.
Cancer-focused faculty are also encouraged to become members of the Louisiana Cancer Research Center, a partnership between the State's foremost cancer research institutions - Tulane University School of Medicine, LSU Health Sciences Center New Orleans, Xavier University of Louisiana and Ochsner Health. Membership in the LCRC provides access to additional funding opportunities exclusively offered to LCRC members. Please click here for the LCRC's membership guidelines and online application form.
| |
Subscribe to Nexus
If you know someone who is interested in subscribing to Nexus, a weekly round-up of news and information for Tulane cancer researchers, please have them contact Melanie Cross at mcross@tulane.edu.
| |
Send Us Your News / Share Your Feedback | |
Please share your feedback. Is this newsletter helpful? What other information should we include? And send us your news and announcements regarding seminars, workshops, funding opportunities, new grants, recent publications or events by emailing Melanie Cross at mcross@tulane.edu.
| | | | |
